ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT07230860

Public ClinicalTrials.gov record NCT07230860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 11:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Moderate to Severe Atopic Dermatitis

Study identification

NCT ID
NCT07230860
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

  • JNJ-95597528 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2026
Primary completion
Nov 18, 2026
Completion
Feb 9, 2028
Last update posted
Apr 12, 2026

2026 – 2028

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
First OC Dermatology Fountain Valley California 92708 Recruiting
Southern California Dermatology Santa Ana California 92701 Recruiting
Driven Research LLC Coral Gables Florida 33134 Recruiting
Arlington Dermatology Rolling Meadows Illinois 60008 Recruiting
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46250 Recruiting
Red River Research Partners LLC Fargo North Dakota 58103 Recruiting
Oregon Dermatology and Research Center Portland Oregon 97210 Recruiting
Clinical Research Philadelphia Philadelphia Pennsylvania 19114 Recruiting
Center for Clinical Studies Houston Texas 77004 Recruiting
Progressive Clinical Research San Antonio Texas 78213 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07230860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07230860 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →